Life Sciences Jobs and Investment Act (H.R. 2632, S. 1410). Patent reform issues (H.R. 1249, S. 23); Pattent settlements (S. 27). Drug reimportation issues (S. 319); Reauthorization of Prescription Drug User Fee Act; Life sciences research tax credit legislation (Life Sciences Jobs and Investment Act--H.R.2632, S. 1410); Healthcare reform bill repeal (H.R. 2); Preserving Access to Orphan Drus Act of 2011 (H.R. 2672, S. 1423); Medicare rebates and reimbursement rates; 340B drug discount program (340B Program Improvement Act--H.R. 2674); Generic Drug and Biosimilar User Fee Act of 2012 (H.R. 3998).
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
155 - Drug Enforcement Administration (DEA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 155 - Drug Enforcement Administration (DEA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 155 - Drug Enforcement Administration (DEA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ENDO INTERNATIONAL
1400 Atwater Drive, Malvern, PA, 19355, US
JAMES BRIAN MUNROE BRENT J FISK CANDIE PHIPPS JAMES BRIAN MUNROE BRENT J FISK CANDIE PHIPPS JAMES BRIAN MUNROE BRENT J FISK CANDIE PHIPPS